Dr. Mario Rocci Joins The IMA Group as Strategic Advisor in Clinical Research
Share Article
The IMA Group announced today that industry veteran Dr. Mario Rocci has joined the company s Clinical Research division as its new Strategic Advisor. Dr. Rocci will help expand the company s office-based, decentralized and virtual clinical trials. TARRYTOWN, N.Y. (PRWEB) January 12, 2021 Mario Rocci, PhD, FCP, FFIP, a seasoned executive with 35 years of scientific and business management experience, has joined The IMA Group (IMA) as Strategic Advisor in the Clinical Research division.
IMA Clinical Research is a network of integrated research sites specializing in Phase II-IV clinical trials in multiple therapeutic areas. IMA performs trials with a flexible model using both their physical locations and virtual capabilities that reach people around the country to support the advancement of safe and effective medication the